Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 47Leukemia, Myeloid, Acute 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Leukemia 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Lymphoma, Non-Hodgkin 23Lymphoma 15Hodgkin Disease 13Leukemia, Myeloid, Accelerated Phase 12Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia, Biphenotypic, Acute 11Blast Crisis 11Myeloproliferative Disorders 10Anemia, Refractory, with Excess of Blasts 10Multiple Myeloma 9Leukemia, Myelomonocytic, Juvenile 8Leukemia, Myeloid, Chronic-Phase 8Hematologic Neoplasms 8Congenital Abnormalities 8Graft vs Host Disease 7Burkitt Lymphoma 7Primary Myelofibrosis 6Myelodysplastic-Myeloproliferative Diseases 6Leukemia, Myelomonocytic, Chronic 6Polycythemia Vera 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

fludarabine phosphate 18Cyclophosphamide 18Peripheral Blood Stem Cell Transplantation 17Busulfan 17Tacrolimus 14Methotrexate 14Mycophenolic Acid 12Antilymphocyte Serum 12Cyclosporine 11Whole-Body Irradiation 9Flow Cytometry 9Filgrastim 7Etoposide 7Radiotherapy 6Methylprednisolone 6Melphalan 6Cord Blood Stem Cell Transplantation 6Therapeutics 5Psychiatric Rehabilitation 5Polymerase Chain Reaction 5Sirolimus 4Immunoenzyme Techniques 4thymoglobulin 3Rituximab 3Ondansetron 3Immunologic Techniques 3Early Intervention, Educational 3Cytarabine 3Cyclosporins 3Aprepitant 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pdgfra-Associated Chronic Eosinophilic Leukemia × Thiotepa × Myeloid × Clear all
NCT00104975 2016-12-15

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Yale University

Phase 1 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡